Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
Erica Zamberletti, Marina Gabaglio, Marie Woolley-Roberts, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 82

Showing 26-50 of 82 citing articles:

Roles of the Notch signaling pathway and microglia in autism
Ying‐Hua Zhang, Ting Wang, Yanfang Li, et al.
Behavioural Brain Research (2022) Vol. 437, pp. 114131-114131
Closed Access | Times Cited: 18
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela‐Scafati, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 17
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
Kunio Yui, George Imataka, Shigemi Yoshihara
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9803-9803
Open Access | Times Cited: 17
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring
Michele Santoni, Claudia Sagheddu, Valeria Serra, et al.
Brain Behavior and Immunity (2023) Vol. 109, pp. 271-284
Open Access | Times Cited: 9
Medical Cannabis: From Research Breakthroughs to Shifting Public Perceptions and Ensuring Safe Use
Muhammad Kamal Hossain, Han‐Jung Chae
Integrative Medicine Research (2024) Vol. 13, Iss. 4, pp. 101094-101094
Open Access | Times Cited: 3
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 23
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Erica Zamberletti, Tiziana Rubino, Daniela Parolaro
Pharmacology & Therapeutics (2021) Vol. 226, pp. 107878-107878
Closed Access | Times Cited: 23
Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal model
Iohanna Deckmann, Júlio Santos‐Terra, Mellanie Fontes‐Dutra, et al.
International Journal of Developmental Neuroscience (2021) Vol. 81, Iss. 7, pp. 579-604
Open Access | Times Cited: 22
Criss‐crossing autism spectrum disorder and adult neurogenesis
Frank Bicker, Leonardo Nardi, Jannik Maier, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 3, pp. 452-478
Closed Access | Times Cited: 22
Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
Aoife M. Thornton, Rachel M. Humphrey, Daniel M. Kerr, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3720-3720
Open Access | Times Cited: 21
Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin
Charlotte M. Pretzsch, Dorothea L. Floris, Bogdan Voinescu, et al.
Molecular Autism (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Autism and associated disorders: cannabis as a potential therapy
Mariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Prenatally VPA exposure is likely to cause autistic-like behavior in the rats offspring via TREM2 down-regulation to affect the microglial activation and synapse alterations
Lijuan Luo, Jie Chen, Qionghui Wu, et al.
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104090-104090
Open Access | Times Cited: 8
The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies
Susanna Pietropaolo, Luigi Bellocchio, Inés Bouzón‐Arnáiz, et al.
Progress in molecular biology and translational science (2020), pp. 183-208
Open Access | Times Cited: 22
Correlation of distinct behaviors to the modified expression of cerebral Shank1,3 and BDNF in two autistic animal models
Raffaella Aló, Ilaria Olivito, Gilda Fazzari, et al.
Behavioural Brain Research (2021) Vol. 404, pp. 113165-113165
Closed Access | Times Cited: 18
In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution
Amy L. Cherry, Michael Wheeler, Karolina Mathisova, et al.
Frontiers in Neuroinformatics (2024) Vol. 18
Open Access | Times Cited: 2
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
Rafael Mariano de Bitencourt, Reinaldo Ν. Takahashi, E.A. Carlini
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 16
Cannabidiol and Other Cannabinoids in Demyelinating Diseases
Carmen Navarrete, Adela García‐Martin, Alain Rolland, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2992-2992
Open Access | Times Cited: 16
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination
Esraa M. Elnahas, Sally A. Abuelezz, Magda I. Mohamad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110522-110522
Closed Access | Times Cited: 11
Retinoic acid administration normalizes aberrant microglial activation via regulating TREM2 transcription in the PFC of valproic acid induced autism rat
Lijuan Luo, Tingyu Li, Qionghui Wu, et al.
Neuroscience Letters (2023) Vol. 803, pp. 137193-137193
Closed Access | Times Cited: 6
The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models
Susanna Pietropaolo, Giovanni Marsicano
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 664-678
Open Access | Times Cited: 15
Long-Term Treatment with Cannabidiol-Enriched Cannabis Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus
Andrey F. L. Aguiar, Raquel Maria Pereira Campos, Alinny Rosendo Isaac, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11775-11775
Open Access | Times Cited: 5
Endocannabinoid System Unlocks the Puzzle of Autism Treatment via Microglia
Tangfeng Su, Yu Yan, Qiang Li, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder
Gahan Pandina, Robert H. Ring, Abigail Bangerter, et al.
Child and Adolescent Psychiatric Clinics of North America (2020) Vol. 29, Iss. 2, pp. 301-317
Closed Access | Times Cited: 12
Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats
Bryan W. Jenkins, Catherine F. Moore, Dan P. Covey, et al.
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. S1, pp. S11-S24
Closed Access | Times Cited: 4

Scroll to top